Capital City Trust Co. FL increased its holdings in Colgate-Palmolive (NYSE:CL) by 3.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,977 shares of the company’s stock after purchasing an additional 1,513 shares during the quarter. Colgate-Palmolive accounts for 1.4% of Capital City Trust Co. FL’s holdings, making the stock its 20th biggest position. Capital City Trust Co. FL’s holdings in Colgate-Palmolive were worth $3,413,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Rainier Group Investment Advisory LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $107,000. CSat Investment Advisory L.P. acquired a new stake in shares of Colgate-Palmolive during the second quarter valued at approximately $111,000. O Brien Wealth Partners LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $123,000. Bridgeworth LLC purchased a new position in Colgate-Palmolive during the second quarter valued at approximately $120,000. Finally, Fort L.P. purchased a new position in Colgate-Palmolive during the second quarter valued at approximately $123,000. Institutional investors and hedge funds own 74.54% of the company’s stock.
CL traded down $1.04 on Thursday, reaching $62.51. 271,448 shares of the company traded hands, compared to its average volume of 3,958,560. The company has a debt-to-equity ratio of -34.49, a quick ratio of 0.74 and a current ratio of 1.06. The company has a market capitalization of $58.10 billion, a PE ratio of 21.78, a PEG ratio of 2.99 and a beta of 0.72. Colgate-Palmolive has a 52-week low of $61.28 and a 52-week high of $77.91.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 27th. The company reported $0.77 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.77. The company had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.91 billion. Colgate-Palmolive had a net margin of 13.97% and a return on equity of 2,494.79%. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.72 earnings per share. On average, equities analysts forecast that Colgate-Palmolive will post 3.02 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 15th. Shareholders of record on Friday, October 19th will be given a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Thursday, October 18th. Colgate-Palmolive’s dividend payout ratio is 58.54%.
A number of research analysts recently commented on the stock. Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating on the stock in a research report on Monday, July 23rd. Wells Fargo & Co lowered their price objective on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research report on Wednesday. ValuEngine raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday, July 2nd. Finally, Barclays set a $64.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Monday, July 30th. Three research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $70.79.
In other Colgate-Palmolive news, insider Mukul Deoras sold 11,334 shares of the business’s stock in a transaction that occurred on Monday, August 13th. The shares were sold at an average price of $65.10, for a total value of $737,843.40. Following the completion of the sale, the insider now directly owns 32,625 shares of the company’s stock, valued at $2,123,887.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Henning I. Jakobsen sold 1,015 shares of the business’s stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $68,055.75. Following the completion of the sale, the chief financial officer now directly owns 36,193 shares of the company’s stock, valued at $2,426,740.65. The disclosure for this sale can be found here. Insiders sold 395,779 shares of company stock valued at $26,108,856 over the last three months. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
See Also: 52-Week High/Low
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.